This page shows the latest Oxford University news and features for those working in and with pharma, biotech and healthcare.
Lateral flow tests can detect COVID-19 in people with high viral loads – who are the most infectious – according to researchers from the University of Oxford. ... prevent further onward spread,” said Tim Peto, professor of medicine at the
Although the progression of antibacterial resistance is a natural process, it is being rapidly exacerbated by the overuse and misuse of antibiotics in humans and also in agriculture processes, Oxford University ... AMR] is arguably the greatest economic
AstraZeneca announced the clinical trial programme in December. A clinical trial that will combine AstraZeneca (AZ)/Oxford University’s COVID-19 vaccine with Russia’s Sputnik V COVID-19 vaccine could ... On 11 December 2020, AZ announced "a clinical
The UK has so far approved three COVID-19 vaccines, from Pfizer/BioNTech (an mRNA-based vaccine), AstraZeneca(AZ)/Oxford University and most recently Moderna.
The UK has so far approved three COVID-19 vaccines: Pfizer/BioNTech’s mRNA-based vaccine, AstraZeneca(AZ)/Oxford University’s vaccine and most recently Moderna’s vaccine. ... While people in the UK have already been receiving the Pfizer/BioNTech
The UK has already approved three COVID-19 vaccines: Pfizer/BioNTech’s mRNA-based vaccine, AstraZeneca(AZ)/Oxford University’s vaccine and most recently Moderna’s vaccine. ... While people in the UK have already been receiving the Pfizer/BioNTech
More from news
Approximately 14 fully matching, plus 134 partially matching documents found.
Multiple groups are advancing vaccines based on similar technology. University of Oxford researchers are enrolling volunteers in a trial of its adenovirus vaccine, while Johnson &Johnson and the US government have
Researchers from Oxford University have also said they plan to start clinical trials of their COVID-19 vaccine this month. ... The CEPI has currently initiated eight COVID-19 vaccine developments with Curevac, Inovio Pharmaceuticals, Moderna, Novavax,
Who knows, it might well have been ‘as cunning as a fox who’d just been appointed Professor of Cunning at Oxford University’ – but his comrades never got to hear it
Vaccitech was launched in a spin-out from Oxford University in May 2016, with the aim of using its novel technology platform to develop a range of innovative new vaccines. ... You took the helm of Vaccitech when it was spun out Oxford University
He is also adjunct professor at the University of Cincinnati, where he teaches data visualisation, and was named the 2016 Outstanding Adjunct Professor of the Year. ... He has over ten years’ experience in data visualisation and business intelligence,
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Ian Walmsey, Pro-Vice-Chancellor Research &Innovation at the University of Oxford and Chair of the RFI’s Interim Board said: “I am delighted that Vivienne has agreed to be the ... I’ve seen how siloed some parts of science and corporate R&D can be
He takes over from Katie Long, who has returned to her role within Tessera Investment Management, having previously established and led Oxford BioDynamics’ finance function. ... A spin-out from Oxford University, Oxford BioDynamics focuses on the
He takes up a senior vice president role. Oxford BioDynamics – a spin out company from the University of Oxford – has appointed Martin Reeves as its new senior vice president, commercial development. ... Christian Hoyer Millar, CEO at Oxford
Standage (pictured right) joins the strategic healthcare communications firm from the University of Cambridge Judge Business School, having recently graduated with a degree in modern languages and management studies. ... Meanwhile Phillips (pictured left)
Formerly, Prof Asbridge served as chief nurse of the Oxford University and Cambridge University teaching hospitals, as well as chief nurse and interim chief executive of Barts and the London NHS
More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.
How significant are the barriers? According to a recent poll conducted by the University of Oxford, while a substantial majority (72%) are in favour of a COVID-19 vaccine, 16% of
Since this initial announcement, other good news in vaccine development has followed, with companies and collaborations, including Moderna and the AstraZeneca/University of Oxford team, publishing similarly positive trial results.
population. There is the same problem in Europe.” Luis E. Raez, MD, of Memorial Cancer Institute/Florida International University in Miami, one of the co-authors. ... The trial is taking place in the UK, led by the University of Oxford.
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the world’s most influential scholarly and professional societies. ... Working in partnership with Oxford
It’s like watching a narrative unfurl before your eyes. During my time as a postdoc at the University of Oxford, I realised this was really what I enjoyed the most: ... I knew that I wanted to move away from the bench, and when I first learned about
More from PMHub
Approximately 0 fully matching, plus 24 partially matching documents found.
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...